2015年6月29日 · Used orally off-label for hereditary angioedema (HAE), to reduce blood loss during and after prostate surgery, and traumatic hyphema (bleeding in the anterior chamber of the eye). TXA is also...

Tranexamic acid injection is an antifibrinolytic indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. ( 1 ) After Extraction: Administer 10 mg/kg actual body weight 3 to 4 times daily for 2 to 8 days.

Xgen Pharma's Tranexamic Acid for Injection is a high-quality hemostatic agent designed to effectively reduce bleeding in a variety of clinical settings. Trusted by healthcare professionals, TXA is a critical tool in the management of hemorrhage, providing reliable and …

Generic Name. Tranexamic Acid Injection, USP. Reference Listed Drug. Cyklokapron® NDC. 81284-611-10. Safety Data Sheet. Click Here PDF. Pack Size. 10 Vials. Strength

Tranexamic Acid (TXA) for Injection Single-Dose Vial 10 mL is a blood-clotting medication that is used to treat and prevent excessive bleeding. It works by stopping the breakdown of blood clots which helps minimize the amount of blood lost during surgery or trauma.

Tranexamic Acid, 100mg/mL, 10mL Vial. Features: Single Dose Vial; Box of 10; NDC#: 23155-0166-41; Prescribing information; Always follow your local protocols regarding product use. ⚠ License Authorization Form Required This product is a prescription drug which requires a Medical Director or Pharmacist-in-Charge to authorize any purchases.

Tranexamic Acid Injection B.P. is indicated for the treatment of increased local fibrinolysis when the diagnosis is indicative of hyperfi brinolysis, as with dental extraction in patients with coagulopathies (in conjunction with antihaemophilic factor).

Tranexamic Acid Injection 100mg/mL SDV 10mL (ea) REFERENCE LIBRARY WHAT’S INCLUDED

Tranexamic Acid (TXA) has existed for decades. Initially used to minimize bleeding during surgical cases, it is now used in the management of trauma patients and post-partum hemorrhage patients with severe hemorrhage and hemorrhagic shock. It is a medication that inhibits the breakdown of fibrin, and thus helps prevent clots from dissolving.

Tranexamic Acid in Sodium Chloride 0.7% IV bags provides clinical potential for a number of medical applications with specific outcome goals. The exela IV bag measures 1000 mg per 100mL multiplying 0.7% sodium chloride v/v as the injection form into RNA Solutions used in a closed clinical setting.